Combination Therapy of GCNT and Tislelizumab in Advanced Biliary Tract Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Combination Therapy of GCNT and Tislelizumab in Advanced Biliary Tract Cancer — Stella

Recruiting

Back to Locally Advanced Biliary Tract Cancers trials

Trial locations(1 site)

South Korea

CHA Bundang Medical Center, Seongnam-si, Gyeonggi-do

Key details

Sponsor

CHA University

Enrollment target

~61 participants

Started

October 2024

Primary completion

May 2026

Age range

19 Years and older

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov